Hcg

Ovulation Induction

Shakeela IshratPhase 3Active

BB

64/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 49/ 100
Competitive Position: 95/ 100

Competitive context

1 Active assets in the Ovulation Induction cohort.

Asset / Sponsor	Phase	Rating
Follitropin Alpha Merck KGaA, Darmstadt, Germany	Phase 4	A
CLOMIPHENE CITRATE University Hospital, Ghent	Phase 4	BB
Folic Acid University Hospital, Ghent	Phase 4	BB
Inositol University Hospital, Ghent	Phase 4	BB
FOLLITROPIN BETA Merck KGaA, Darmstadt, Germany	Phase 3	BB

View all 10 →

Same molecule, other indications

Hcg is also rated in:

polycystic ovary syndromeDormant

BBB

Indicative ·

79 / 100

infertility disorderDormant

BBB

Indicative ·

78 / 100

In Vitro FertilizationDormant

BBB

Indicative ·

73 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.